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Women’s experiences being diagnosed with peripartum cardiomyopathy: 
A qualitative study 
PRECIS 
Despite experiencing severe symptoms, nearly 40% of women with peripartum cardiomyopathy 
experienced delays in diagnosis due to symptom dismissal by health care professionals. 
 
ABSTRACT 
Background: Cardiovascular disease has been identified as the leading cause of maternal 
mortality in the United States, with cardiomyopathy, including peripartum cardiomyopathy 
(PPCM) accounting for 12-16% of all pregnancy-related deaths. The purpose of this study was to 
describe women’s experience of being diagnosed with PPCM.  
Methods: This investigation was conducted using a qualitative design. We collected publicly 
available narratives posted by 92 women with PPCM (29 ± 6 years old, ejection fraction 25.5% ± 
10.8) in 3 online support groups. Data were coded and thematically organized so as to produce a 
richly detailed account of this experience.   
Results: The experience of diagnosis was marked by the women’s distinct memories of their 
initial symptoms and whether they were dismissed or taken seriously. The most commonly 
reported symptoms were extreme shortness of breath, orthopnea, tachycardia, palpitations, chest 
pain, cough, and edema. Only half of women reported that care providers initially took their 
symptoms seriously, while a quarter of the women experienced dismissal by health care 
providers. One-fourth of women were initially given inaccurate diagnoses ranging from “new 
mom anxiety” to asthma. Women described their initial reaction to diagnosis as feeling terrified, 
devastated, and feeling a sense of doom. Women had difficulty caring for their newborns during 
the postpartum period, and they struggled with the medical advice they received to not get 
pregnant again.  
Conclusion: Despite experiencing severe subjective and objective symptoms, about one quarter 
of women with PPCM experienced symptom dismissal by health care providers, in part due to 
the overlap between normal symptoms of pregnancy and symptoms of heart failure.  
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QUICK POINTS 
 Some women with peripartum cardiomyopathy (PPCM) experience a delay in diagnosis 
due to symptom dismissal by health care professionals 
 Women have strong emotional reactions to the diagnosis of PPCM, and they struggle 
with the advice they receive not to get pregnant again. 
 Midwives should be alert to the fact that PPCM is a potential pregnancy and postpartum 
complication 
 Midwives can help women with PPCM understand their prognosis and discuss the 
dilemma of future childbearing 
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Women’s experiences being diagnosed with peripartum cardiomyopathy:  
A qualitative study  
This qualitative study aimed to describe women’s experience of being diagnosed with 
peripartum cardiomyopathy (PPCM), defined as the idiopathic development of heart failure and 
left ventricular systolic dysfunction towards the end of pregnancy or in the months following 
birth.1 Women with PPCM almost always have a reduced left ventricular ejection fraction of less 
than 45% (normal values range from 55-65%).1 The incidence of PPCM has risen from 1 in 
4,350 live births in 1990-93, to 1 in 2,229 live births in 2000-02,2 and is currently 1 in 968 
births.3 It is not clear whether this increase in PPCM diagnoses is related to an increase in 
cardiovascular disease risk factors among pregnant women, implementation of the European 
Society of Cardiology’s 2010 expanded diagnostic criteria for PPCM, improved identification of 
PPCM, or a combination of all three of these factors.3  
Capturing women’s PPCM diagnosis experience is important because cardiovascular 
disease has been identified as the leading cause of maternal mortality in the United States, with 
cardiomyopathy, including PPCM, accounting for 12-16% of all pregnancy-related deaths.4,5,6 
Furthermore, delays in care have been identified as contributory to potentially preventable 
cardiovascular (CVD) deaths.6,7 The absolute risk of mortality from PPCM varies, depending on 
the time period and geographic location in which women are studied. Retrospective studies in the 
U.S. have revealed absolute PPCM mortality rates ranging from 1.4% to 18%.1,7 One study found 
an incidence of 3.61 per 10,000 births and a 16.5% fatality rate over 7 years, with African 
American women demonstrating a 4-fold higher prevalence and fatality compared with white 
women.7  
A diagnosis of PPCM is also associated with significant morbidity, including ventricular 
dysrhythmias, thromboembolisms and chronic dilated cardiomyopathy.8 To make timely and 
accurate diagnoses, midwives and other health care providers should understand how women 
identify symptoms and seek medical care, as symptomatology is easily confused with “normal 
discomforts” of late pregnancy or postpartum.8   
Our aims were to identify how women describe being diagnosed with PPCM; the 
symptoms that led them to seek care; the quality of interactions with clinicians during the 
diagnostic process, and the impact of the diagnosis. Researchers have examined risk factors and 
long-term health outcomes in mothers with PPCM; however, only one group has reported a 
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qualitative study of the experience of living with PPCM, using comments made in a MySpace 
chat room.9 Data on women’s experiences with PPCM diagnosis and treatment by health care 
providers are limited, and so we undertook data analysis of in-depth narratives written by women 
with PPCM. 
METHODS 
Study Design and Sample 
This qualitative study analyzed publicly available narratives posted by women diagnosed 
with PPCM from 3 websites in mid-2012: “My Heart Sisters,” “A Woman’s Heart” (no longer 
online), “PPCMnet” (no longer online). We downloaded 92 narratives and anonymized them 
prior to analysis. The Institutional Review Board at Stanford University determined this study 
was not considered human subjects research because data consisted of narratives publicly 
available on websites.  
Data Analysis 
Each narrative file was copied verbatim, given a unique pseudonym, and transferred into 
the data management software, Dedoose, version 6.2.8 (SocioCultural Research Consultants, 
LLC, Manhattan Beach, California). We extracted the following data from each narrative: age at 
diagnosis, parity; year and mode of birth; indication for induction and/or cesarean; 
complications; and ejection fraction (EF) value at diagnosis and a second time point. Narratives 
contained limited data in terms of race, marital status, and obstetric history. 
Investigators coded and analyzed the text data using thematic analysis according to the 
methods of Braun and Clarke.10 Approaches to thematic analysis are varied, as are criteria for 
determining what constitutes a “theme” in qualitative research. As Braun and Clarke themselves 
acknowledge, thematic analysis is not wedded to a particular epistemology and instead benefits 
from the flexibility needed to provide a rich, detailed and complex account of data in a number 
of epistemological domains. Our methodological focus was on the examination of themes in 
experience. The present study aims to make sense of the women’s experience by hewing closely 
to their own narrative structure. Each narrative was read, re-read, and coded. The narratives were 
compared to ensure that coding was consistent throughout. We deductively coded expected 
themes such as “identifying symptoms,” “seeking medical care,” “getting a diagnosis,” 
“treatment and recovery,” and “finding meaning.” We also sought emergent concepts and 
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themes. Examples of codes that emerged from the data analysis include “initial reactions” and 
“not normal for me.”10    
We took several steps to encourage rigor,11 including designing the study and analyzing 
data with multiple investigators, meeting frequently throughout data analysis to assure the results 
reflected the data, and reflexively considering investigator influence in all aspects of the analysis. 
Analytic triangulation was enhanced by the participation of 2 nurse-researchers, a sociologist, 
and a social psychologist. 
RESULTS 
Description of Sample 
Some women described recent diagnoses, in which prognoses were uncertain. Other 
narratives were written years after diagnosis, representing the perspectives of long-term 
survivors. Contextual information provided in the narratives—such as idioms, phrases, language 
clues, and mention of geographic settings—allowed us to determine that the majority of women 
who provided narratives likely received care in the U.S. However, it was also clear that from 
some narratives (7%), women were from other countries including the United Kingdom, 
Australia, Canada and the Netherlands.   
Table 1 shows demographic and clinical characteristics obtained from the narratives. Not 
all narratives included this information. About half of women reported being diagnosed after 
their first pregnancy, while the other half was diagnosed after a subsequent pregnancy. The 
majority of women (75.0%) reported receiving a PPCM diagnosis between 2000 and 2006, while 
25.0% were diagnosed between 2007 and 2012.  Of the 69 women who mentioned mode of birth, 
72.5% gave birth by Cesarean, while 27.5% gave birth vaginally. About 40% of the sample 
mentioned experiencing either preeclampsia or hypertension during pregnancy. The average 
ejection fraction (EF) upon diagnosis was 25.5% (SD 10.8, range 5%-54%), and the average EF 
upon telling the story was 49.5% (SD 11.5, range 15%-75%).   
Diagnosis Experience 
Reports of initial diagnoses of PPCM or congestive heart failure (CHF) were marked by the 
women’s distinct memories of their symptoms, and whether these symptoms were dismissed or 
taken seriously by themselves, their family/friends, and health care professionals.  As women 
narrated their stories, they referred to the accuracy (or not) of initial diagnoses, and examples of 
encounters with a variety of health care providers.  
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Initial Symptoms. Women described a range of symptoms, including extreme shortness of 
breath, especially when lying down, very high heart rate, palpitations, chest pressure, cough or 
asthma unresolved with treatment, excessive edema or swelling, anxiety or restlessness, and 
significant fatigue or inability to carry out everyday tasks. “My main symptoms were chest pain 
and sweating. I literally thought I was having a heart attack every second of the day.”  
Symptom Dismissal. Nearly 40% of women described how having their symptoms 
dismissed by physicians and nurses as normal for pregnancy: “Two days after my daughter was 
born I started to feel as if I couldn't breathe, it was hard work just getting out of bed. I reported 
this to a nurse who said, ‘Of course you're breathing, you haven't turned blue.’”  
Women also described not receiving thorough physical exams after reporting symptoms. One 
woman described how a physician didn’t check her swollen ankles—a friend later informed her 
that she had severe pitting edema. Another woman reported not receiving any physical 
assessment and being told that her “suffocating” orthopnea was “normal.”  
Inaccurate Diagnoses. While most women were diagnosed correctly when they initially 
sought treatment, nearly a third (n = 26) reported first being diagnosed with a condition other 
than PPCM, including: pneumonia, influenza, the common cold, fluid in lungs from magnesium 
sulfate treatment, gallbladder disease, asthma, “new mom” anxiety, panic attack, stress of having 
a colicky baby, pulmonary embolus, postpartum depression, and mitral valve regurgitation.  
One woman described going to the Emergency Room with severe shortness of breath 
(SOB) and rapid heartbeat. After 24 hours of being treated for a potential blood clot, new onset 
asthma, and postpartum depression, she was finally diagnosed with PPCM only after she began 
to lose consciousness: 
 
I kept begging them to call the doctor and give me something else for the SOB. They 
offered to call the hospital psychiatrist because they thought I was depressed about not 
being with my children. After a few hours…when I began to pass out, they rushed me 
back to ICU. This time my 02 [oxygen saturation] was around 30 and my heart rate was 
over 200…. I was in critical condition. I just remember passing out about 5 times. They 
did a bedside electrocardiogram and then determined it must be PPCM.   
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When Symptoms Were Taken Seriously. Approximately half of the women (54%) described 
having their symptoms taken seriously by a care provider and then being promptly referred to a 
specialist for cardiac evaluation. However, sometimes women’s symptoms were not taken 
seriously until after they had already been dismissed.  
 
I kept complaining to the nurses I couldn't breathe normally....perhaps they considered 
me a hysterical new mommy; they gave me Xanax. I stayed awake the entire night; I 
simply couldn't breathe when I lay down. At seven am, I became frightened. When the 
nurse (not the one who gave me Xanax, thank God) entered, my oxygen level dropped to 
84. I was on my hands and knees, gasping for air. The nurse immediately ran out and I 
was wheeled to the emergency room and one hour later, I was told I was in congestive 
heart failure and had PPCM. 
  
Strategies Used to Seek Care. A number of women (20%) described making multiple 
visits to seek care and receive a diagnosis, and 18% sought a second opinion before being 
diagnosed. Women who had given birth before could compare their symptoms to their first 
pregnancy, and knew that what they were experiencing was abnormal. However, some first-
time mothers did not have a framework for knowing what was normal or abnormal, and were 
more hesitant to push for answers. One first-time mother described having an uncomplicated 
vaginal birth, and noticing 2 months postpartum she was gaining unexplained weight. She 
began an exercise regimen and thought her symptoms were a result of a too-vigorous workout.  
Her internist agreed and prescribed an anti-inflammatory medication.  A week later she 
complained of such severe orthopnea and breathlessness that her physician finally ordered an 
EKG, and she was promptly admitted to the hospital for cardiac evaluation.  
Quality of Interactions with Clinicians. Some women assumed clinicians were 
uncaring when symptoms were not taken seriously: “During all this, I was still trying to 
breathe. We kept telling everyone something was wrong but they didn’t seem to care.  I 
knew that if I stayed there I was going to die.” Conversely, women whose diagnoses 
occurred quickly after onset of symptoms expressed appreciation, especially in contrast to 
other accounts where the journey to diagnosis took much longer: “I understand reading 
these other bios that I am extremely lucky to be alive and to have had my condition 
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diagnosed so quickly. I am very grateful to all the hospital staff that cared for me during 
my week in the hospital.”  
Impact of the Diagnosis 
The second major theme we identified was the impact of the diagnosis. Women described 
their initial reaction to the diagnosis, coordinating care for a newborn, the impact on future 
childbearing and relationships, and moving forward with their lives.  
Initial Reaction. Women reported experiencing a broad range of emotions in response to 
the diagnosis, but the most commonly reported were feeling scared, afraid, or terrified, especially 
in conjunction with an initial pessimistic prognosis:  
Some women heard their diagnosis when they were alone. Some also used strong words 
evoking the depth of their emotions, such as devastating, a sense of doom, hysterical, freaking 
out and emotional torture: 
 
The cardiologist came in the next day when no one in my family was there, and explained 
what happened to me and that my heart was functioning at 20%. He told me that I might 
need a heart transplant, and that I was finished being pregnant. Of course I was 
hysterical. I called the nurse in and she could see how upset I was. I think she gave that 
Dr. a talking to, because a few hours later he came and apologized to me.  
 
A few women had backgrounds in health care, yet even for them, the shock of hearing the 
diagnosis and prognosis was overwhelming:  
 
Within fifteen minutes of officially being diagnosed I was told by the doctors that I: 1) 
could have no more children, 2) had to immediately stop breastfeeding, 3) was being 
admitted to the ICU, and 4) the heart transplant team would be in touch within 24 
hours… I was so upset they ended up giving me a sedative. 
 
Managing Care for a Newborn. Between the shock of hearing the diagnosis, and the 
experience of feeling physically ill, women and their families still had to care for a newborn. 
This became more complicated when the mother was transferred to another facility or ICU, and 
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the baby was well enough to be discharged home. Family members had to choose between 
supporting the woman and caring for the baby:  
 
I was transferred to a teaching hospital for they were looking into a double transplant 
option to keep me alive. We have no family in the area and my beautiful healthy babies 
were at home with my mother. My mother wanted to be with my husband and me. My 
husband was desperate for help and called the ob/gyn's office for a nurse referral. He left 
our babies with a complete stranger! 
 
Even having support was problematic, when it reminded women of all they could not do: 
“I was fortunate to have a sister who had a baby just 5 weeks before me who was able to pump a 
bottle of breast milk for my baby every day, but that same act of love also depressed me and was 
a constant reminder that I wasn't well.”  
Thirteen women wrote about separation concerns—women were in the ICU, and found 
away from their babies very difficult, at times more difficult than being critically ill. They 
described how meaningful it was when nurses recognized the value of seeing their baby: “I 
didn’t get to see my son for the first 3 days but then a wonderful nurse let my boyfriend bring 
him in and all I could do was cry!”  
Impact on Childbearing. Nearly half (42 out of 92) of the women were given advice 
against future childbearing at the same time, or close to, hearing their PPCM diagnosis. All but 
one of these women were advised against future pregnancies. Only 8 of the 42 women indicated 
they pursued sterilization to avoid future pregnancies. A few women who weren’t planning to 
have more children were matter-of-fact about their next steps, weighing their current situation 
against the risks of future childbearing.  
Of those who talked about future childbearing, 29 out of 42 were first-time mothers and 
many struggled to accept the advice to not get pregnant again: “I am very depressed by the fact 
that my husband and I will not be able to have any more children. This news is completely 
devastating to me.” 
Several women ended their narratives with no clear direction as to whether they would try 
for a future pregnancy; a few noted they received conflicting advice from physicians about the 
risks of doing so. Women often framed the decision about future childbearing around the 
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potential impact of another episode of heart failure on spouses and children: “I was told right 
from the beginning not to have any more children which upsets me but I could not go through 
that again, or put my family through that again, maybe even leave my daughter and another child 
without a mother.”  
Five women noted that they were in recovery, had achieved normal EFs, and were being 
weaned off heart medications. These five women were cautiously optimistic about the possibility 
of another pregnancy. Some asked for women who have given birth successfully after PPCM to 
share their stories. 
Nine women had pregnancies after their PPCM diagnosis. Six were unplanned (one was 
pregnant at time of posting the narrative) and 5 were monitored in pregnancy and reported good 
outcomes. Three women planned pregnancies after their PPCM diagnoses: 2 reported 
uncomplicated pregnancies and good outcomes, and 1 experienced a relapse of PPCM.  Women 
conflicted about having more children stated that reading the stories of women who had 
successful post-PPCM pregnancies gave them hope.  
Impact on Relationships. Several women spoke about the impact of the diagnosis on their 
marriages and relationships with family members.  Some women had families who rallied and 
pitched in to care for the baby and support the new parents. Yet even with supportive family, 
some women found themselves forced into solutions that required long periods of separation 
from their babies so they could focus on their own recovery: 
 
The worst of it was that they put me on a 5 pound lifting restriction, which meant I wasn’t 
even able to pick up my newborn son.... The day before I was released from the hospital, 
my husband, my parents, and my in-laws got together and decided that I would stay with 
my parents, my husband would move in with his parents, and my son would be shuffled 
between my parents’ and in-laws’ houses every weekend… we didn’t feel we had much 
choice. 
 
Others spoke of the lasting toll on their loved ones:  
 
PPCM stole so much from me and my family. My sister almost didn't get pregnant 
because of what she saw me go through. She only had one child and had so much anxiety 
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through her pregnancy that she didn't have another. That makes me feel guilty. 
Sometimes I look at the ripple effect that PPCM caused and I want to take a sword to it 
and cut it in half...like it did me. 
  
Other women had to go on disability and were concerned that they would not be able to work, 
and they did not have health insurance or a way to contribute to the household income.  
Moving Forward. Most women ended their narratives with a brief summary of their 
prognosis, and some included expressions of faith and gratitude for their current health status.  
Several spoke of the mixed blessing of receiving such a diagnosis, with its lifelong implications:  
 
I'm glad that I lived to see Mackenzie's 10th birthday. I'm bitter. I'm thankful. I'm grateful 
to be alive. I'm pissed. I'm all of these things. 
 
Many women also offered encouragement to anyone who might read their story, and 
invited others to contact them if they needed someone to talk with about their diagnosis.  
DISCUSSION 
One of the key findings of our study is that despite having severe subjective and objective 
symptoms, one-quarter of women experienced symptom dismissal by health care professionals. 
When some women presented with complaints of severe breathlessness, orthopnea, palpitations, 
and even chest pressure, their care providers did not include PPCM among the differential 
diagnoses, resulting in delayed diagnosis and treatment. Our finding is supported by Hess’ et 
al.’s qualitative analysis of MySpace chat room comments, written by women with PPCM.9 Hess 
et al. found that women used terms such as “dismissed” and “brushed off” when describing 
seeking treatment for PPCM symptoms. Our study differs from Hess et al.’s in that we included 
women with diagnoses as recent as 2012 who documented their experiences via in-depth 
narratives that followed a distinct story-telling pattern, while Hess et al. analyzed PPCM chat 
room postings from 2005-2008, and some of these postings discussed more than one topic.  
In both our study and Hess et al.’s study, some women experienced initial misdiagnoses 
such as anxiety or normal pregnancy symptoms. Unfortunately, there is considerable overlap 
between symptoms of PPCM and those of normal pregnancy, which can contribute to treatment 
delay. Dyspnea, dizziness, edema, and orthopnea can occur in normal pregnancies,12 and up to 
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80% of pregnant women experience peripheral edema.13 In a recent study describing 
cardiovascular disease-related maternal deaths in California between the years 2002-2006, 
researchers estimated that 13 of the 29 dilated cardiomyopathy maternal deaths (45%) were due 
directly to health care providers’ failure to respond promptly to warning signs in the patient’s 
history and clinical exam, leading to a delay in diagnosis.7  
To help reduce symptom dismissal and improve the outcomes of women with PPCM, it is 
important for midwives, physicians, and nurses who work with pregnant and postpartum women 
to be aware of PPCM symptoms and keep this rare but serious differential diagnosis in mind 
when working with a mothers who have potential cardiac-related complaints. Women who are 
age 40 or older, obese, African American, or have a history of diabetes, hypertension, or 
substance abuse, are at additional risk factors for developing PPCM. However, regardless of the 
presence of risk factors for PPCM, midwives should include a cardiac etiology in their 
differential diagnosis if any of the following red flags are present on physical exam: shortness of 
breath at rest, orthopnea, resting heart rate > 120 beats per minute, resting systolic blood pressure 
> 160 mm Hg, resting respiratory rate of > 30 breaths per minute and an oxygen saturation < 
94%.6 The presence of any red flags indicates a need for prompt evaluation and referral to a 
primary care physician, maternal-fetal medicine specialist, or cardiologist. While waiting for the 
referral, midwives can immediately order an electrocardiogram (EKG) and a B-type natriuretic 
peptide (BNP) laboratory test. The BNP is a simple, inexpensive screening test that—if 
elevated—is highly specific for left ventricular systolic dysfunction. According to the California 
Maternal Quality Care Collaborative’s soon-to-be-released toolkit on PPCM, a positive result on 
a BNP or EKG indicates a high suspicion for cardiovascular disease.14 
In our study, we found that women had strong emotional reactions upon learning their 
PPCM diagnosis. Our finding is consistent with Hess’s qualitative study,9 in which women with 
PPCM used terms such as “shocked” and terrified” when they described receiving their 
diagnosis. The diagnosis of PPCM needs to be given in a sensitive manner, in the presence of the 
woman’s support system. Women also need accurate, evidence-based information about their 
risk of mortality and prognosis for recovery. Although women in our study found the diagnosis 
of PPCM to be a terrifying experience, actual survival rates are high. In 2000, Felker et al.15 
found that women with PPCM have a 94% survival rate at 5 years. The high survival rate is 
possibly due to the younger age and less comorbidity at diagnosis in comparison to patients 
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diagnosed with heart failure due to other causes.12,15 In one registry study, 78% of mothers with 
PPCM regained normal systolic function, and all women with an EF of 35% or higher at the time 
of diagnosis eventually recovered.16  
Consistent with Hess et al.’s study,9 many women in our study voiced concerns about the 
impact of PPCM on their future childbearing potential. Evidence shows that approximately one-
third of women who get pregnant will experience a relapse.17 The risk of experiencing PPCM is 
related to a woman’s current cardiac function and is thus individualized.17 Therefore, women 
with PPCM may need ongoing counseling as to the pros and cons of future childbearing, types of 
birth control available, potential for relapse should they become pregnant, and the importance of 
avoiding pregnancy while they still have a reduced EF.18 
Patient stories are increasingly recognized as central to medical care,19 and our findings 
suggest PPCM narratives generate rich data. More clinical research on PPCM is needed, using 
mixed-methods or qualitative components to capture women’s experiences and integrate them 
with treatment and outcome data, to achieve truly patient-centered recommendations for care. 
However, the fact that two groups of qualitative researchers have now documented similar 
themes from women with PPCM—experiencing dismissal by care providers, feeling terrified 
during the diagnosis-telling, and being distressed about future pregnancies—makes it clear that 
clinicians can take action to provide better emotional and informational support for women with 
this rare diagnosis. The results from our study reflect the importance of listening to a woman’s 
complaints of severe symptoms, and valuing women’s knowledge of what is normal and 
abnormal for them. 
Limitations 
Our study was limited by its collection of pre-existing narratives posted prior to 2012 on 
peer support websites focused on peripartum cardiomyopathy, without the opportunity to collect 
full demographic data and obstetric histories, or to ask women further about their experiences. 
The inability to explore the written narratives further with women truncates researchers’ ability 
to clarify meaning and range of variation in the data. Furthermore, the use of internet narratives 
limits the sample to persons with internet access and effective written communication skills. 
However, given that PPCM is a rare diagnosis, this method allowed us to analyze findings from a 
much larger sample than would have been practical in a traditional study.  
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Women in our study were at differing points in the diagnosis journey – rarely in the midst 
of the crisis, but instead months or years later. Similarly, the diagnosis experience occurred in 
diverse settings over a wide range of time. Despite these limitations, the large number of 
narratives and the recurrent themes represent a rich perspective on women’s experiences 
receiving a PPCM diagnosis. We believe that future investigators who conduct research on 
women with PPCM should include a mixed-methods approach, collecting women’s experiences 
as well as assessing their emotional and mental health response to the PPCM diagnosis. 
CONCLUSIONS 
Despite experiencing severe subjective and objective symptoms, nearly 40% of women 
with PPCM experienced symptom dismissal by health care providers, partially due to the overlap 
between normal pregnancy symptoms and symptoms of heart failure. Clinicians who work with 
women of childbearing age should be knowledgeable about PPCM symptoms and keep this rare 
but serious differential diagnosis in mind when encountering women who experience severe 
edema, dyspnea, orthopnea, or tachycardia. Health care providers can help women diagnosed 
with PPCM to understand their prognosis and how PPCM will impact future childbearing.  
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Table 1: Reported demographic and clinical characteristics from women’s PPCM narrativesa (N 
= 92) 
Demographic and Clinical 
Characteristics 
Number Reporting 
(%)  
Mean ± standard 
deviation 
Age at diagnosis 
 
50 (54.3) 
Range 17- 41 
29.1 (6) 
 
Parity 91 -- 
First pregnancy 49 (50.5) -- 
Second pregnancy 24 (24.7) -- 
Third pregnancy  10 (10.3) -- 
Fourth or higher 8 (8.2) -- 
Unreported 1 -- 
Year of diagnosis 76 (82.6) -- 
Prior to 2000  14 (18.4) -- 
2000-2006 43 (56.6) -- 
2007-2010  19 (25.0) -- 
Unreported 16 -- 
Mode of birth 69 (75.0) -- 
Vaginal 19 (27.5) -- 
Cesarean 50 (72.5) -- 
Unreported 23 -- 
Indication for Cesareanb 44 (47.8) -- 
Failed induction 17 (38.6) -- 
Maternal condition  11 (25.0) -- 
Malposition 5 (11.4) -- 
Fetal distress 5 (11.4) -- 
Failure to progress 2 (.05) -- 
Scheduled or repeat 2 (.05) -- 
Twin birth 2 (0.5) -- 
Unreported 6  -- 
18 
 
Demographic and Clinical 
Characteristics 
Number Reporting 
(%)  
Mean ± standard 
deviation 
Initial diagnosis 87 (94.6%) -- 
Peripartum cardiomyopathy or 
congestive heart failure 
68 (77.3) -- 
Pneumonia 8 (9.1) -- 
Pulmonary edema 2 (2.3) -- 
Preeclampsia  4 (4.5) -- 
Hypertension 1 (1.1) -- 
Asthma 2 (2.3) -- 
Postpartum depression 2 (2.3) -- 
Preeclampsia or hypertension during 
pregnancy 
 -- 
Preeclampsia 16 (16.5) -- 
Hypertension 21 (21.6) -- 
No mention of preeclampsia or 
hypertension  
55 (59.8) -- 
Initial ejection fraction  77 25.5 (10.8) 
Range 5-54% 
Most recent ejection fraction 72 49.5 (11.5) 
Range 15-75% 
aNot all narratives contained all demographic and clinical characteristics compiled in this table.   
bIndications for Cesarean were not always explicitly stated by the women and the categories here 
were assigned by the researchers. 
